Id |
Subject |
Object |
Predicate |
Lexical cue |
T698 |
0-24 |
Sentence |
denotes |
Declaration of Interests |
T699 |
25-251 |
Sentence |
denotes |
N.B. serves as an advisor/board member for Neon, Checkpoint Sciences, Primevax, Novartis, Array BioPharma, Roche, Avidea, Boeringer Ingelheim, Rome Therapeutics, Roswell Park, and the Parker Institute for Cancer Immunotherapy. |
T700 |
252-362 |
Sentence |
denotes |
N.B. receives research support from the Parker Insitute, Novocure, Celldex, Genentech, Oncovir, and Regeneron. |
T701 |
363-482 |
Sentence |
denotes |
M.M. serves as an advisor/board member for Celsius, Pionyr, Compugen, Myeloids and Innate pharma and ad hoc for Takeda. |
T702 |
483-552 |
Sentence |
denotes |
M.M. receives research support from Regeneron, Takeda, and Genentech. |
T703 |
553-618 |
Sentence |
denotes |
A.M. has equity in Gilead Sciences and Regeneron Pharmaceuticals. |